• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    Load latest
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 13 May 2025
    Trump's Drug-Price Order Won't Impact Indian Pharma Companies: Kiran Mazumdar-Shaw
    Trump's Drug-Price Order Won't Impact Indian Pharma Companies: Kiran Mazumdar-Shaw
    NDTV Profit
    Trump has issued an executive order, directing drugmakers to lower the prices of medicines to align with what other countries pay.
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 12 May 2025
    Trump's drug price plan sends ripples through Indian Pharma sector
    Business Line
    Trump's anticipated announcement threatens to implement a most favoured nation policy that could potentially reduce US drug prices by 30-80%
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 09 May 2025
    India To Reduce Import Duties On Medical Devices Covered In PLI Scheme Under FTA With UK
    India To Reduce Import Duties On Medical Devices Covered In PLI Scheme Under FTA With UK
    NDTV Profit
    While the import duty on the sector is up to 7.5% in India, it stands at 4.2% in the UK.
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 07 May 2025
    Medical device company share price zooms 47% in 1 month. Do you own?
    Business Standard
    Poly Medicure, a leading medical device company with a dominant position in India's medical consumables market, rallied 5 per cent to 2,922 on the BSE in Wednesday's intra-day trade.
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 04 May 2025
    Medicines are just one part of the solution: Zydus' Sharvil Patel
    Business Standard
    Zydus MD Sharvil Patel says the company is going beyond pharma into med-tech, diagnostics, and rare diseases, aiming for a global footprint while retaining India as the manufacturing hub
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 04 May 2025
    Study finds men more likely to fall sick, die from 3 common health issues
    Business Standard
    Men in many countries are more likely to fall sick and die from hypertension, diabetes, and HIV/AIDS as compared to women, according to a new study. However, compared to women, men were found to be less likely to seek medical care and adhere to treatment for these common health conditions due to norms related to masculinity and healthcare financing. Men were also more likely to smoke, while women were more likely to be obese and engage in unsafe sex, the study, published in the journal PLOS Medicine, found. The research highlights sex-based differences at each step of the "health pathway", which includes being exposed to a risk factor -- such as smoking -- developing a condition, diagnosis, treatment and death, study authors said. "Most of these differences are not explained by sex (biology) alone, but by socially-constructed gender -- highlighting the importance of taking a gender justice approach to reducing health inequities. A gender analysis can help to shape systems of health
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 24 Apr 2025, 05:58AM
    Pharma companies set for strong performance in March 2025 quarter amid earning weakness
    Pharma companies set for strong performance in March 2025 quarter amid earning weakness
    Economic Times
    Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic therapies in India.
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 18 Apr 2025
    JB Chemicals Gets USFDA Nod For Generic Hypertension Drug
    JB Chemicals Gets USFDA Nod For Generic Hypertension Drug
    NDTV Profit
    The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of high blood pressure.
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 10 Apr 2025
    HIV spike stuns Uttarakhand hospital with 477 cases in just 15 months
    Business Standard
    According to reports, the majority of patients are men and few infected children likely contracted the virus from mothers
    Copy LinkShare onShare on Share on Share on
    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 08 Apr 2025

    Q4FY25 Earnings Preview - Pharma & Healthcare

    buy
    Pharmaceuticals & Biotech.
    by Axis Direct
    Axis Direct
    We recommend BUY on Lupin, Aurobindo, Abbott India, Fortis, and Max Health.
    Copy LinkShare onShare on Share on Share on
    Alert  
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd